SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367920-22-000003
Filing Date
2022-02-03
Accepted
2022-02-03 16:06:02
Documents
12
Period of Report
2022-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cnce-20220131.htm   iXBRL 8-K 34824
  Complete submission text file 0001367920-22-000003.txt   174299

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20220131.xsd EX-101.SCH 1917
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20220131_lab.xml EX-101.LAB 24791
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20220131_pre.xml EX-101.PRE 13056
6 EXTRACTED XBRL INSTANCE DOCUMENT cnce-20220131_htm.xml XML 12032
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 22588282
SIC: 2834 Pharmaceutical Preparations